Cytochrome P450 3A5 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Cytochrome P450 3A5 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Cytochrome P450 3A5 |
| Clone | [F18 P3 B6] |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG1 |
| Format | Protein A purified |
| Size | 0.2 mg |
| Concentration | n/a |
| Applications | ELISA (EIA), Western Blot (WB), Immunohistochemistry (IHC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CYP3A genes encode monooxygenases, enzymes which catalyze drug metabolism and the synthesis of cholesterol, steroids and other lipids. CYP3A (cytochrome P450, family 3, subfamily A), the most abundant p450 enzyme in human liver, is responsible for the metabolism of more than 50% of all clinical drugs. CYP3A members localize in organs that associate with drug disposition, including the liver, gastrointestinal tract and kidney. The CYP3A cluster consists of four genes: CYP3A43, CYP3A4, CYP3A7 and CYP3A5, and two pseudogenes: CYP3A5P1 and CYP3A5P2. The CYP3A cluster maps to gene locus 7q21.3-q22.1. |
| Immunogen | Immunogen: Hybridoma produced by the fusion of splenocytes from BALB/c mice immunized with a synthetic peptide derived from the C-terminus of the human CYP3A5 protein and mouse myeloma Ag8563 cells. |
| Other Names | [CYP3A5; CYP450 3A5 (EC 1.14.14.1); Niphedipine oxidase; CYPIIIA5; P450-PCN3; HLp2], [CYP3A5; CYP3A5; CP35; PCN3; CYPIIIA5; P450PCN3] |
| Gene, Accession # | Gene ID: 1577, NCBI: NP_000768.1, UniProt: P20815 |
| Catalog # | MBS395286 |
| Price | $340 |
| Order / More Info | Cytochrome P450 3A5 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies